CD44 and cancer: CD44 is a non-kinase transmembrane receptor that binds to hyaluronan, a proteoglycan secreted by stromal cells in response to interactions with tumor cells, and is thought to play an important role in cancer progression by activating cell signaling pathways and by modulating cytoskeletal changes favoring motility [22, 23].